A pharmaceutical company is expanding a recent recall of a blood pressure medication that may contain chemicals known to cause cancer.
Products manufactured by Accord Healthcare (formerly Actavis) and Dexcel Pharma, which contain irbesartan, may have been contaminated with N-nitrosodiethylamine (NDEA) - a carcinogenic chemical that was formerly used in rocket fuel.
Losartan is used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy and for the treatment of nephropathy in Type 2 diabetic patients.
The list of Valsartan products under recall can be found here and the list of Valsartan products not under recall can be found here.
Adverse reactions to the medication can also be reported to the FDA. The FDA says patients should continue to take their medication but contact a doctor immediately to seek advice on a new treatment strategy.
A list of losartan medications under recall can be accessed via the FDA's website (pdf).
"Aurobindo is recalling lots of valsartan-containing medication that tested positive for NDEA above the interim acceptable daily intake level of 0.083 parts per million", according to the agency. The Food and Drug Administration announced Aurobindo Pharma USA, Inc.is voluntarily recalling 80 lots of Amlodipine Valsartan Tablets, Valsartan HCTZ Tablets, and Valsartan Tablets. The drug is sold by several manufacturers, and in July of 2018 nearly a half-dozen companies were forced to recall their products due to the discovery of human carcinogens in the tablets.